A B O U T U S
Neuroplast is a Dutch clinical stage stem cell technology company with a European Orphan Designation, focusing on fast-track development programs. Neuroplast develops autologous stem cell treatments to improve and extend the lives of people who suffer from neurodegenerative diseases, that pressure healthcare expenditure, when no other treatments are available.
Neuroplast Neuro-Cells® is classified as an Advanced Therapy Medicinal Product (ATMP) tissue engineered product by the European Medicine Agency (EMA). Neuro-Cells® is produced under the ATMP Good Manufacturing Practice (GMP) guidelines and in a fully GMP certified production facility in Geleen, The Netherlands.